Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Cytomegalovirus Infection

Free Subscription Articles published in Clin Infect Dis Retrieve available abstracts of 17 articles: HTML format

Single Articles

May 2025
1. FUNG JST, Wright RC, Bharaj DK, Alghamdi A, et al
   Virus-specific T-cell therapy for prophylaxis and treatment of cytomegalovirus infections after transplantation: a scoping review.
   Clin Infect Dis. 2025 May 6:ciaf232. doi: 10.1093.
   PubMed     Abstract available
   
   
   March 2025
2. VELAPHI S, Madewell ZJ, Tippett-Barr B, Blau DM, et al
   Investigating the role of cytomegalovirus as a cause of stillbirths and child deaths in low and middle-income countries through postmortem minimally invasive tissue sampling.
   Clin Infect Dis. 2025 Mar 10:ciaf098. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2024
3. HELDMAN MR, Boeckh MJ, Limaye AP
   Current and future strategies for the prevention and treatment of cytomegalovirus infections in transplantation.
   Clin Infect Dis. 2024 Nov 4:ciae535. doi: 10.1093.
   PubMed     Abstract available
   
   
   August 2024
4. 
   Correction to: Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir With Valganciclovir.
   Clin Infect Dis. 2024 Aug 2:ciae356. doi: 10.1093.
   PubMed    
   
   
   July 2024
5. CUELLAR-RODRIGUEZ JM, van Duin D
   Cytomegalovirus Disease: Fine-Tuning Clinical Trial Enrollment and Standardization.
   Clin Infect Dis. 2024 Jul 29:ciae319. doi: 10.1093.
   PubMed    
   
   
   
6. LJUNGMAN P, Chemaly RF, Khawaya F, Alain S, et al
   Consensus Definitions of Cytomegalovirus (CMV) Infection and Disease in Transplant Patients Including Resistant and Refractory CMV for Use in Clinical Trials: 2024 Update From the Transplant Associated Virus Infections Forum.
   Clin Infect Dis. 2024 Jul 23:ciae321. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2024
7. HAMMOND SP, Little JS
   How much does cytomegalovirus viremia matter after chimeric antigen receptor T-cell therapy?
   Clin Infect Dis. 2024 Feb 2:ciae053. doi: 10.1093.
   PubMed    
   
   
   
8. KAMPOURI E, Boeckh MJ, Hill JA
   Understanding the clinical significance of cytomegalovirus viremia after chimeric antigen receptor T-cell therapy: Should we be treating a value?
   Clin Infect Dis. 2024 Feb 2:ciae030. doi: 10.1093.
   PubMed    
   
   
   January 2024
9. YATES TA, Halliday N
   Re: Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Reci
   Clin Infect Dis. 2024 Jan 9:ciae004. doi: 10.1093.
   PubMed    
   
   
   
10. KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al
    Response to Yates and Halliday regarding CMV DNAemia and time-to-mortality in a Randomized Trial of PET vs AP in CMV D+R-Liver Transplant Recipients.
    Clin Infect Dis. 2024 Jan 8:ciae005. doi: 10.1093.
    PubMed    
    
    
    November 2023
11. PAPANICOLAOU GA, Avery RK, Cordonnier C, Duarte RF, et al
    Treatment for First Cytomegalovirus Infection Post-Hematopoietic Cell Transplant in the AURORA Trial: A Multicenter, Double-Blind, Randomized, Phase 3 Trial Comparing Maribavir with Valganciclovir.
    Clin Infect Dis. 2023 Nov 30:ciad709. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. KAMPOURI E, Ibrahimi SS, Xie H, Wong ER, et al
    CMV Reactivation and CMV-Specific Cell-Mediated Immunity after Chimeric Antigen Receptor T-Cell Therapy.
    Clin Infect Dis. 2023 Nov 17:ciad708. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2023
13. KUMAR L, Dasgupta S, Murray-Krezan C, Singh N, et al
    Association of CMV DNAemia with Long-Term Mortality in a Randomized Trial of Preemptive Therapy (PET) and Antiviral Prophylaxis (AP) for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative (D+R-) Liver Transplant Recipien
    Clin Infect Dis. 2023 Oct 20:ciad643. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2023
14. MANUEL O, Laager M, Hirzel C, Neofytos D, et al
    Immune monitoring-guided vs fixed duration of antiviral prophylaxis against cytomegalovirus in solid-organ transplant recipients. A Multicenter, Randomized Clinical Trial.
    Clin Infect Dis. 2023 Sep 22:ciad575. doi: 10.1093.
    PubMed     Abstract available
    
    
    
15. PORTILLO V, Masouridi-Levrat S, Royston L, Yerly S, et al
    Revisiting cytomegalovirus serology in allogeneic hematopoietic cell transplant recipients.
    Clin Infect Dis. 2023 Sep 15:ciad550. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2023
16. AMIR J, Chodick G, Pardo J
    Revised protocol for secondary prevention of congenital cytomegalovirus infection with valaciclovir following infection in early pregnancy.
    Clin Infect Dis. 2023 May 9:ciad230. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2023
17. PLOTKIN SA
    Can We Prevent Congenital Infection By Cytomegalovirus?
    Clin Infect Dis. 2023 Mar 28:ciad179. doi: 10.1093.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Cytomegalovirus Infection is free of charge.